Navigation Links
DrugRisk Center Adds Latest on First of 3,000 Actos Bladder Cancer Trials
Date:3/28/2013

New York, NY (PRWEB) March 28, 2013

The prescription drug resource center DrugRisk.com is announcing new information to the site for those who have taken the medication Actos for diabetes. With drug maker Takeda facing claims from patients alleging bladder cancer, the first trial is underway in California.

The goal of DrugRisk is to improve the safety of patients taking popular prescription drugs by providing the most up-to-date warnings, recalls, studies and legal news. Visitors can determine if others have experienced similar side effects and decide if they need legal advice.

The resource center contains warnings from experts such as the FDA and European Medicines Agency*, who have warned that long-term use of Actos may be associated with an increased bladder cancer risk. The drug has also been banned in France and Germany**.

Although Actos remains on the market in the United States, DrugRisk has learned that as many as 3,000 patients have filed an Actos lawsuit against drug maker Takeda Pharmaceuticals alleging they developed bladder cancer***. Over 1,200 of these have been consolidated in a special multi-district federal court in Louisiana, while others are pending in California.

The resource center has added information from the first of these Actos lawsuit trials, which began this month in California for a retired man dying of bladder cancer***. A former pharmacologist for Takeda testified that, as news of bladder cancer risks spread, executives were more concerned with maintaining sales than the safety of patients***.

Anyone affected by bladder cancer after taking Actos is urged to contact DrugRisk or speak with a lawyer about their legal rights as soon as possible. Lawyers are still helping those affected file claims.

Due to the specialized nature of drug injury litigation, however, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

To learn more about the studies linking Actos to bladder cancer, as well as Actos side effects and legal news, or to speak with a lawyer, visit http://www.DrugRisk.com today.

*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos; ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/hu an_pha_detail_000033.jsp&mid=WC0b01ac058001d126
**cbsnews.com/8301-504763_162-20070492-10391704.html
***bloomberg.com/news/2013-03-05/takeda-put-actos-sales-ahead-of-user-safety-witness-says.html; Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court (Los Angeles).

Read the full story at http://www.prweb.com/releases/actos-lawsuits/bladder-cancer-lawsuit/prweb10579370.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
10. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
11. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 09, 2016 , ... A new leadership team for Mid-South ... President Joe Wiley made the announcement Monday night, Feb. 8, prior to the evening ... of FHU and the creator of GO! Camp, has been named director. Gayle McDonald, ...
(Date:2/10/2016)... (PRWEB) , ... February 09, 2016 , ... ... at Clevens Face and Body Specialists are delighted to welcome a new addition ... joins Clevens Face and Body Specialists as a nurse practitioner performing cosmetic ...
(Date:2/10/2016)... ... February 09, 2016 , ... Traumatic ... cause of injury may be one of many possible sources: sports, car accidents, ... Education Course , Mastering Rehab Solutions for the Complexities of Concussions ...
(Date:2/9/2016)... Florida (PRWEB) , ... February 09, 2016 , ... Steven ... the Taste of South Florida Event, an upscale fundraiser held in South Florida. The ... sponsors and guests alike. This year the event will be held in a new, ...
(Date:2/9/2016)... ... February 09, 2016 , ... Interstate Restoration LLC, a full ... today the acquisition of Hawaii DKI. Hawaii DKI is one of the more ... companies who excel at service and response helps support our goal of becoming ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Blood Monitoring & Cardiac Monitoring Devices Market Assessment & Forecast: 2015-2019" ... market for blood monitoring & cardiac monitoring devices was valued at ... 24,830.1 million by 2019 at a CAGR of 6.8% from 2015 ... Europe , Asia-Pacific , Latin ... Africa . The three major factors determining growth of the ...
(Date:2/9/2016)... , Feb. 9, 2016  Increasingly, health care ... their vital signs with wireless technology. With the Vios ... automate patient oversight and remotely detect problems before they ... signs across in-hospital environments. the United ... United States . --> The ...
(Date:2/9/2016)... , Feb. 9, 2016  Johnson & Johnson (NYSE: ... Markets Global Healthcare Conference on Tuesday, Feb. 23, at ... Dominic Caruso , Vice President, Finance & Chief Financial ... will represent the Company in a session scheduled at ... --> www.investor.jnj.com . --> This ...
Breaking Medicine Technology: